
The Amsterdam office of global law firm Greenberg Traurig, continues its strategic growth with the addition of Local Partner Dr. Robert Hardy, who joins the firm’s Antitrust Litigation & Competition Regulation practice on 1 December 2021. Hardy previously worked at Simmons & Simmons and Skadden, Arps, Slate, Meagher & Flom.
“I am honoured and thrilled to join Greenberg Traurig‘s Antitrust Litigation & Competition Regulation Practice, and am committed to sustaining its further growth and development in Amsterdam and elsewhere,” Hardy said. With over 13 years of extensive experience, Hardy’s practice covers a wide range of issues under Dutch and European competition law. He represents clients before the Dutch Competition Authority (ACM), the European Commission, the Dutch administrative law courts, and the EU courts in matters relating to cartels, dominance, merger control, and State aid proceedings.
Greenberg Traurig’s Amsterdam Managing Shareholders Cees van Oevelen and Thomas van der Vliet commented that they are very pleased that Hardy is joining the firm in Amsterdam: “This is again an important addition to the firm. Robert advises clients on high-value and complex matters spanning a wide spectrum of economic sectors. His particular interest in the interface between intellectual property and competition law is a new and important step in our strategic growth.” Hans Urlus, who heads the Amsterdam Antitrust Litigation & Competition Regulation Practice for the firm, added: “Robert brings a lot of experience in EU merger control work, having worked with other top-tier U.S. firms in Brussels for quite some time, and will also help to expand the firm’s broader regulatory practice in the EU.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DoorDash, Grubhub, and Uber Eats Settle With NYC Over Cap Fees
Apr 30, 2025 by
CPI
Pork Giants Push to Overturn Price-Fixing Suit Citing Clerk’s Alleged Conflicts
Apr 30, 2025 by
CPI
Novartis to Acquire Regulus Therapeutics in $1.7 Billion Deal
Apr 30, 2025 by
CPI
India’s Competition Commission Clears J&K Bank in Antitrust Case
Apr 30, 2025 by
CPI
Spain’s Antitrust Watchdog Clears BBVA’s Sabadell Bid With Conditions
Apr 30, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece